Mia's Feed
Medical News & Research

Research Connects COVID-19 and Bacterial Infections to Alzheimer's Disease Development

Research Connects COVID-19 and Bacterial Infections to Alzheimer's Disease Development

Share this article

Recent studies reveal that infections like COVID-19 and bacterial agents may contribute to Alzheimer's disease through inflammation and neural invasion, opening new avenues for prevention and therapy.

2 min read

A recent comprehensive review by researchers at the Philadelphia College of Osteopathic Medicine (PCOM) highlights the potential link between infectious agents such as SARS-CoV-2 (the virus responsible for COVID-19) and Chlamydia pneumoniae bacterial infections with the development of Alzheimer's disease. The study emphasizes that both pathogens can elevate levels of inflammatory substances called cytokines, particularly IL-6 and CCL2, which contribute to neuroinflammation—a process damaging brain cells and potentially accelerating the accumulation of harmful proteins characteristic of Alzheimer's.

The review, published in Frontiers in Aging Neuroscience, explains that these infections can infiltrate the central nervous system through the blood-brain barrier or, more notably, via the olfactory route responsible for our sense of smell. This route is significant because the olfactory epithelium can serve as an entry point for pathogens, allowing them to travel along olfactory nerves directly into brain regions associated with memory and cognition. Notably, loss of smell is an early symptom in both COVID-19 and Alzheimer’s, underscoring the importance of this pathway.

Furthermore, the research discusses how individuals with certain genetic risk factors, such as the APOEε4 allele, may be more vulnerable to these infections, thereby increasing their risk of developing Alzheimer’s. The study synthesizes peer-reviewed evidence, shedding light on how microbial invasion and subsequent inflammation can impact brain health.

Expert insights from Dr. Brian J. Balin, a leading researcher at PCOM, suggest that understanding these mechanisms could pave the way for new strategies in the prevention and treatment of Alzheimer’s Disease. The ongoing exploration into infectious triggers aims to deepen our understanding of the disease’s origins, potentially transforming future approaches to managing neurodegeneration.

This research underscores the significance of infection control in neurological health and highlights the complex interactions between infectious agents and neurodegenerative processes. For more details, visit the original publication here.

Stay Updated with Mia's Feed

Get the latest health & wellness insights delivered straight to your inbox.

How often would you like updates?

We respect your privacy. Unsubscribe at any time.

Related Articles

Humans Are Intrinsically Seasonal Creatures Driven by Circadian Rhythms

New research uncovers that humans retain strong seasonal biological rhythms, influencing sleep, mood, and health, despite modern lifestyles. Discover how our circadian clocks are still tuned to daylight changes year-round.

'Fast-Fail' AI Blood Test Offers Rapid Assessment for Pancreatic Cancer Treatment Response

Researchers at Johns Hopkins have developed a rapid AI-powered blood test that detects tumor DNA fragments, enabling quicker assessment of treatment response in pancreatic cancer patients—potentially transforming personalized care.

Higher Risk of Opioid Overdose Deaths Among Female and Minority Veterans

Research reveals that female veterans and racial/ethnic minority groups are at greater risk of dying from opioid overdoses, highlighting urgent needs for targeted interventions.